New Key Statistics Module, Z-Score and F-Score
NAS:IART Key Ratios
| Market Cap $ M | 2,469.68 |
| Enterprise Value $ M | 3,889.43 |
| P/E(ttm) | 37.86 |
| PE Ratio without NRI | 11.86 |
| Forward PE Ratio | 9.81 |
| Price/Book | 1.55 |
| Price/Sales | 1.64 |
| Price/Free Cash Flow | 34.19 |
| Price/Owner Earnings | 74.45 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,541.00 |
| EPS (TTM) $ | 0.83 |
| Beneish M-Score | -2.57 |
| 10-y EBITDA Growth Rate % | 11.80 |
| 5-y EBITDA Growth Rate % | 8.10 |
| y-y EBITDA Growth Rate % | -30.30 |
| EV-to-EBIT | 29.37 |
| EV-to-EBITDA | 15.20 |
| PEG | 1.46 |
| Shares Outstanding M | 78.60 |
| Net Margin (%) | 4.39 |
| Operating Margin % | 7.24 |
| Pre-tax Margin (%) | 5.26 |
| Quick Ratio | 2.18 |
| Current Ratio | 3.45 |
| ROA % (ttm) | 1.79 |
| ROE % (ttm) | 4.07 |
| ROIC % (ttm) | 2.86 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.79 |
| Piotroski F-Score | 4.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
IART Number of Guru Trades
IART Volume of Guru Trades
Gurus Latest Trades with NAS:IART
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IART is held by these investors
Total 3
Integra Lifesciences Holdings Corp Insider Transactions
No Available Data
News about NAS:IART
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers